A Community Celebration of Cancer Research, Entrepreneurship & Women’s Leadership
The AIM-HI Accelerator Fund (AIM-HI), together with our partner organizations, [...]
AIM-HI Accelerator Fund Honors Anna D. Barker, Ph.D., with Inaugural Beacon Award for Women Leaders in Oncology
ROCKVILLE, MD – The AIM-HI Accelerator Fund (AIM-HI) today announced the recipient of [...]
Come With Us! 2022 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship
The AIM-HI Accelerator Fund (AIM-HI) brings together a worldwide community [...]
AIM-HI Accelerator Fund Nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Accelerator Fund Announces Inaugural Beacon Award for Women Leaders in Oncology
ROCKVILLE, MD – AIM-HI Accelerator Fund, a non-for-profit that focuses [...]
2022 AIM-HI Women’s Venture Competition Announced 6 Semi-Finalists!
The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the [...]
First in the World! Arbele’s CDH17xCD3 Bispecific Antibody Received Clinical Trial Phase I Ethics Approval in Australia
On March 31, 2022, the clinical trial application of ARB202 [...]
Leading Game-changing Discoveries | Sujuan Ba, Ph.D.
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI CEO & Co-Founder Featured as ‘Scientist Trailblazing the Transformation’
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
2021 Highlights: Thank You for Supporting AIM-HI to Accelerate a Cure!
The year 2021 saw an unprecedented triumph of science as [...]
